Cargando…
Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor
The aim of the present work is the development of highly efficient targeting molecules to specifically address mesoporous silica nanoparticles (MSNs) designed for the photodynamic therapy (PDT) of prostate cancer. We chose the strategy to develop a novel compound that allows the improvement of the t...
Autores principales: | Bouffard, Elise, Mauriello Jimenez, Chiara, El Cheikh, Khaled, Maynadier, Marie, Basile, Ilaria, Raehm, Laurence, Nguyen, Christophe, Gary-Bobo, Magali, Garcia, Marcel, Durand, Jean-Olivier, Morère, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600508/ https://www.ncbi.nlm.nih.gov/pubmed/31181759 http://dx.doi.org/10.3390/ijms20112809 |
Ejemplares similares
-
Mannose 6‐phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease
por: Godefroy, Anastasia, et al.
Publicado: (2019) -
Photosensitivity of Different Nanodiamond–PMO Nanoparticles in Two-Photon-Excited Photodynamic Therapy
por: Bondon, Nicolas, et al.
Publicado: (2022) -
Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate
por: Miller, James J., et al.
Publicado: (2021) -
Multifunctional Gold-Mesoporous Silica Nanocomposites for Enhanced Two-Photon Imaging and Therapy of Cancer Cells
por: Croissant, Jonas G., et al.
Publicado: (2016) -
Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor
por: Arighi, Cecilia N., et al.
Publicado: (2004)